Skip to main content

HEALTH

  • Exergen's temporal artery thermometer outsells competing brands

    WATERTOWN, Mass. — For the second consecutive year, the Exergen temporal artery thermometer outsold all other brands at retailers nationwide, Exergen announced Thursday.

  • Medco: Cancer drugs to see huge rise by 2013

    ORLANDO, Fla. — Cancer drugs are expected to see sharp increases in spending and use by 2013, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions.

    The overall drug trend for 2010 was 3.7%, lowered by higher rates of generic drug dispensing; more than 71% of drugs dispensed were generics. Specialty drugs, mostly branded biologics, accounted for 70.1% of the overall drug trend, with especially strong growth in cancer drugs, whose drug trend reached 21.2%.

  • IMS Health: Global spending on medicines to reach nearly $1.1 trillion by 2015

    PARSIPPANY, N.J. — Global spending on medicines will reach nearly $1.1 trillion by 2015, according to a new study by market research firm IMS Health.

  • Ford developing health care in the dashboard

    DEARBORN, Mich. — Ford Motor on Wednesday announced its research partnership with WellDoc — a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs — around integrating WellDoc services into Ford vehicles through the automaker’s SYNC voice-activated in-car connectivity system.

    That SYNC system also will enable access to SDI’s Pollen.com Allergy Alert application, Ford announced Wednesday.

  • Perrigo receives final approval for generic Zantac 150

    ALLEGAN, Mich. — Perrigo on Monday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter ranitidine 150 (regular and cool mint), a generic version of Zantac 150.

    Zantac 150 has annual sales of approximately $110 million, as measured by SymphonyIRI Group, Perrigo reported.

  • NSF International says Nordic Naturals facility complies with GMP

    WATSONVILLE, Calif. — Nordic Naturals on Tuesday announced the company has earned certification from NSF International, verifying that its new Leadership in Energy and Environmental Design corporate headquarters complies with good manufacturing practices.

    "NSF's exceptional commitment to public safety is in line with our own values and Nordic Naturals' mission to deliver pure, safe and effective omega oils worldwide,” stated Joar Opheim, Nordic CEO.

  • Clif Bar launches social site Meet the Moment

    EMERYVILLE, Calif. — Clif Bar on Monday introduced Meet the Moment, a social site where people can share inspiring athletic photos and stories of accomplishment.

    As part of the site launch, at MeettheMoment.com, Clif Bar will award three people who upload the most inspirational and creative moments by July 31 an opportunity to pursue their dream adventure. Each winner will select the adventure of their choice (up to a maximum value of $12,000).

  • FDA advisory committee to discuss safety, efficacy of Trilipix

    SILVER SPRING, Md. — A Food and Drug Administration panel will discuss findings in a clinical trial that has raised concerns about the safety and efficacy of Abbott's cholesterol-lowering drug when it’s combined with similar drugs, according to an FDA announcement.

X
This ad will auto-close in 10 seconds